|
MYOBLOC® (Botulinum Toxin Type B) gains expanded access in First Coast Service Options’ Florida and Connecticut Medicare programs
MALVERN , PA – June 15, 2006 – Solstice Neurosciences Inc., has received expanded access coverage for Myobloc® (Botulinum Toxin Type B) Injectable Solution for First Coast Service Options’ (FCSO) Medicare patients in Florida and Connecticut. The expanded access coverage went into effect May 8, 2006.
Solstice submitted an official Reconsideration Request to FCSO to expand the reimbursement beyond the treatment of Cervical Dystonia (spasmodic torticollis). In recognition of patient needs and physician demands, FCSO responded favorably to the request to allow reimbursement for a broader range of therapeutic codes. “The use of MYOBLOC may be considered a medically necessary off-label indication for spasticity caused by stroke or brain injury", as noted on the CMS website. (For more information visit: http://www.cms.hhs.gov/mcd/viewlcd.asp?lcd_id=5840&lcd_version=14&show=all)
The revised policy offers a broader range of therapeutic options to optimize care for patients with significant disabilities.
About Solstice Neurosciences, Inc.:
Founded in 2004, Solstice Neurosciences, Inc. is a biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty products. Solstice’s first product, Myobloc® (Botulinum Toxin Type B) Injectable Solution 5,000U/mL, represents the only botulinum toxin type B currently available to physicians and patients worldwide. MYOBLOC is sold in the United States and approved in Canada. It is also sold and distributed in Europe as NeuroBloc®. MYOBLOC is indicated for the treatment of patients with cervical dystonia (CD) to reduce the severity of abnormal head position and pain associated with CD. For more information about Solstice Neurosciences, Inc., visit www.solsticeneuro.com
About Cervical Dystonia:
Cervical Dystonia (CD), also known as spasmodic torticollis, is a condition that primarily affects the muscles of the head and neck (the cervical area of the spine). Cervical dystonia is the most common dystonia requiring referral to movement disorder clinics. The neck muscles contract involuntarily causing abnormal movements and positions of both the head and neck. Muscle spasms in the neck often cause great pain, contributing significantly to the disability caused by the disorder. Treatment is aimed at relaxing contracted muscles and reducing pain.
Contact:
Diane Murray, Director-Business Operations & Communications
Phone: Toll Free (866)220-5042, or Direct (267)620-8056
Email : diane.murray@solsticeneuro.com
MYOBLOC is a registered trademark of Solstice Neurosciences, Inc.
|
